Motus Files Pure-Vu Version US Application For Use During Upper GI Endoscopy

by Vandana Singh, Benzinga Editor

April 6, 2021 9:57 AM | 23 seconds read | Make a Comment

Motus GI Holdings Inc MOTS has submitted a 510(k) application to the FDA for a version of the Pure-Vu System.
The new version of the system is compatible with gastroscopes used during upper gastrointestinal (GI) endoscopy procedures to remove blood, blood clots, and debris to provide a clear field-of-view for the endoscopist.
Price Action: MOTS shares are down 2.45% at $1.20 on the last check Tuesday.

Posted In: Biotech News Penny Stocks Health Care FDA General Briefs endoscopy

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.